Controversies in IBD
Section editors' commentary. Usefulness of Crohn's disease activity index in medicine
Peter A. Banks M.D.,
Daniel H. Present M.D.,
Peter A. Banks M.D.
Search for more papers by this authorDaniel H. Present M.D.
Search for more papers by this authorPeter A. Banks M.D.,
Daniel H. Present M.D.,
Peter A. Banks M.D.
Search for more papers by this authorDaniel H. Present M.D.
Search for more papers by this authorFirst published: 18 April 2007
References
- 1 Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. Gastroenterol 1976; 70: 439–44.
- 2 Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514.
- 3 Landi B, Anh TN, Cortot A, Soule JC, Rene E, Gendre JP, Bories P, See A, Metman EH, Florent C, Lerebours E, Mary JY, Modigliani R. Groupe D Etudes Therapeutiques des Affections Inflammatoires Digestives. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. Gastroenterol 1992; 102: 1647–53.
- 4 Korelitz BI, Adler DJ, Mendelsohn RA, Sacknoff AL. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol 1993; 88: 1198–1205.
- 5 Felder JB, Adler DJ, Korelitz BI. The safety of cortcosteroid therapy in Crohn's disease with an abdominal mass. Am J Gastroenterol 1991; 86: 1450–5.
- 6 Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981–7.
- 7 Targan SR, Hanauer SB, van Deventer JH, Mayer L, Present DH, Braakman T. DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med 1997; 337: 1029–35.
- 8 Bauditz J, Haemling J, Ortner M, Lochs H, Raedler A, Schreiber S. Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease. Gut 1997; 40: 470–4.
- 9 Stack WA, Mann SD, Roy AJ, Heath P, Sopwith M, Freeman J, Holmes G, Long R, Forbes A, Kamm MA, Hawkey CJ. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease. Lancet 1997; 349: 521–4.
- 10 Van Dullemen HM, Van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterol 1995; 109: 129–35.
- 11 Chun A, Chadi RM, Korelitz BI, et al, Intravenous corticotrophin vs. hydrocortisone in the treatment of hospitalized patients with Crohn's disease: a randomized double-blind study and follow-up. Inflammatory Bowel Diseases 1998; 4: 177–81.
